Skip to main content

Pressure Injury

3
Pipeline Programs
5
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
2 programs
1
1
Mepilex Border Flex®Phase 41 trial
SEM ScannerPhase 21 trial
Active Trials
NCT06127524Active Not Recruiting4,733Est. Jun 2026
NCT04884737Completed107Est. Mar 2023
Rehabtronics
RehabtronicsAB - Edmonton
1 program
1
IES SystemPhase 31 trial
Active Trials
NCT04328246Terminated4Est. Mar 2022
Integra LifeSciences
Integra LifeSciencesAustralia - Clayton
1 program
MicroMatrix® FlexN/A1 trial
Active Trials
NCT06629506Completed25Est. Aug 2025
Providence Therapeutics
1 program
PreliviaN/A1 trial
Active Trials
NCT06435143Not Yet Recruiting20Est. Nov 2024
Wellell
WellellTaiwan - New Taipei City
1 program
Use of a powered alternating pressure air mattressN/A1 trial
Active Trials
NCT05472974Completed86Est. Jul 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsMepilex Border Flex®
RehabtronicsIES System
Angeles TherapeuticsSEM Scanner
Integra LifeSciencesMicroMatrix® Flex
Providence TherapeuticsPrelivia
WellellUse of a powered alternating pressure air mattress

Clinical Trials (6)

Total enrollment: 4,975 patients across 6 trials

NCT04884737Angeles TherapeuticsMepilex Border Flex®

Decreasing Intraoperative Skin Damage in Prone Position Surgeries

Start: Jul 2021Est. completion: Mar 2023107 patients
Phase 4Completed
NCT04328246RehabtronicsIES System

Pressure injuRy preventiOn by inTermittent EleCtrical sTimulation

Start: Feb 2021Est. completion: Mar 20224 patients
Phase 3Terminated
NCT06127524Angeles TherapeuticsSEM Scanner

Skin Change Actions by Nursing

Start: Dec 2023Est. completion: Jun 20264,733 patients
Phase 2Active Not Recruiting
NCT06629506Integra LifeSciencesMicroMatrix® Flex

MicroMatrix® Flex in Tunneling Wounds

Start: Dec 2024Est. completion: Aug 202525 patients
N/ACompleted
NCT06435143Providence TherapeuticsPrelivia

Validation and Usability Study of Intermittent Electrical Simulation in Management of Pressure Injuries Stages 1 and 2

Start: Jun 2024Est. completion: Nov 202420 patients
N/ANot Yet Recruiting
NCT05472974WellellUse of a powered alternating pressure air mattress

Prevention of Pressure Ulcers in Patients at Medium to High Risk of Developing Pressure Ulcers and Using the DOMUS 4 / AUTO Motorized Air Mattress

Start: Sep 2018Est. completion: Jul 201986 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.